RELIEF THERAPEUTICS HLDG AG (RLFTF, $2.75) was a top loser over the last three months, falling -1 to $2.75 per share. A.I.dvisor analyzed 831 stocks in the Biotechnology Industry for the 3-month period ending June 6, 2025, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.